% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • mousemouse595 mousemouse595 Aug 31, 2012 9:41 AM Flag

    CEO clearly lied here is the proof

    He said multiple offers but failed to release anything public which means he got no offers

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • CEO did not lie in June,2011 in his comments to Bloomberg.The offers were closer to 15 than 30.
      Read the statement carefully.
      Now--in June,2011, Amarin had
      1) No patents
      2) Vascepa was not approved
      3) Anchor 3 trial data for 200-500mg polulation was NOT available--This is a big opportunity.
      4) Reduce-It study costing 120 mil.$ was not launched.
      How can PFE or AZN or others offer price over 20 in May,2011?
      Facts now are better--that is why 8 analysts--are estimating Value between 21.50 to 28$/share.
      What is missing?
      approval for 200-500mg.trigl.population--expected by Aug.2013
      Sales for Vascepa
      Based on Lipitor analogy from 1996-99,Vascepa is in 1996 stage.
      1997-98 provided sales data,bidding followed in 1999.
      Price offered -90 bil.$ in 1999 was 3 times what Pfizer was willing to offer in 1996.

      Sentiment: Strong Buy

3.20+0.04(+1.27%)Oct 21 4:00 PMEDT